Estados financieros detallados de Cardiff Oncology, Inc. (CRDF): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Cardiff Oncology, Inc. registró ingresos de $593000 en el último ejercicio fiscal, con un CAGR de 5 años del 10.1%.
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -83.2%, margen neto -78.8%.
Al precio actual de $1.35, CRDF presenta beneficios negativos (P/E no significativo) y un ROE del -103.08%. La capitalización bursátil es de $104M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $381000 | $505000 | $378000 | $244632 | $366000 | $359000 | $386000 | $488000 | $683000 | $593000 |
| Coste de Ventas | $1.7M | $1.8M | $597000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$1.3M | -$1.3M | -$219000 | $244632 | $366000 | $359000 | $386000 | $488000 | $683000 | $593000 |
| I+D | $15.0M | $7.9M | $8.2M | $11.2M | $11.2M | $17.4M | $27.1M | $32.9M | $36.9M | $35.3M |
| Generales y Administrativos | $23.0M | $14.2M | $8.0M | $5.8M | $8.2M | $11.8M | $13.2M | $13.0M | $12.5M | $14.2M |
| Gastos Operativos | $38.0M | $22.1M | $16.2M | $16.9M | $19.5M | $29.2M | $40.3M | $45.9M | $49.3M | $49.6M |
| Beneficio Operativo | -$40.1M | -$25.6M | -$17.1M | -$16.7M | -$19.1M | -$28.9M | -$39.9M | -$45.4M | -$48.7M | -$49.0M |
| EBITDA | -$36.8M | -$22.8M | -$15.7M | -$15.9M | -$18.8M | -$27.8M | -$38.5M | -$41.0M | -$45.0M | -$44.9M |
| Gastos por Intereses | $1.4M | $1.0M | $25409 | 0 | $2000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$39.2M | -$24.9M | -$16.5M | -$16.4M | -$19.3M | -$28.3M | -$38.7M | -$41.4M | -$45.4M | -$45.9M |
| Impuestos | -$296000 | $716000 | $617643 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$39.2M | -$24.9M | -$16.5M | -$16.4M | -$19.3M | -$28.3M | -$38.7M | -$41.4M | -$45.4M | -$45.9M |
| BPA | $-93.54 | $-51.71 | $-7.06 | $-2.70 | $-1.08 | $-0.73 | $-0.89 | $-0.93 | $-0.95 | $-0.69 |
| BPA Diluido | $-93.22 | $-51.71 | $-7.06 | $-2.70 | $-1.08 | $-0.73 | $-0.89 | $-0.93 | $-0.95 | $-0.69 |
| Acciones en Circulación (Diluidas) | $420568 | $481665 | $2.3M | $6.0M | $20.9M | $39.0M | $43.6M | $44.7M | $47.6M | $66.8M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $37.9M | $8.2M | $11.5M | $10.2M | $131.0M | $11.9M | $16.3M | $21.7M | $51.5M | $17.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $128.9M | $88.9M | $53.2M | $40.3M | $40.8M |
| Cuentas por Cobrar | $100460 | $77095 | $167755 | $203480 | $320000 | $535000 | $771000 | $288000 | $773000 | $182000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $39.0M | $9.5M | $12.8M | $11.4M | $133.4M | $146.1M | $111.3M | $77.4M | $95.1M | $60.1M |
| Inmovilizado Material | $3.8M | $2.4M | $1.3M | $1.6M | $967000 | $3.2M | $3.5M | $2.9M | $2.1M | $1.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $44.0M | $12.3M | $14.2M | $13.1M | $134.7M | $149.5M | $116.2M | $81.6M | $97.2M | $61.9M |
| Cuentas por Pagar | $1.1M | $825244 | $664840 | $656304 | $1.4M | $1.4M | $2.0M | $2.0M | $4.8M | $8.1M |
| Deuda a Corto | $2.4M | $1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $7.8M | $3.9M | $3.0M | $4.8M | $6.1M | $6.6M | $7.8M | $10.4M | $13.4M | $16.4M |
| Deuda a Largo | $14.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $24.2M | $5.8M | $4.1M | $5.8M | $6.6M | $9.1M | $9.8M | $11.9M | $14.2M | $16.5M |
| Reservas | -$148.1M | -$173.0M | -$192.2M | -$208.9M | -$231.5M | -$259.8M | -$298.1M | -$339.5M | -$384.2M | -$430.0M |
| Patrimonio Neto | $19.8M | $6.5M | $10.1M | $7.3M | $128.2M | $140.4M | $106.3M | $69.7M | $82.9M | $45.4M |
| Deuda Total | $16.5M | $1.3M | 0 | $1.7M | $869000 | $3.1M | $2.7M | $2.1M | $1.5M | $832000 |
| Deuda Neta | -$21.4M | -$6.9M | -$11.5M | -$8.5M | -$130.1M | -$137.7M | -$102.6M | -$72.7M | -$90.2M | -$57.5M |
| Capital Circulante | $31.2M | $5.5M | $9.8M | $6.6M | $127.2M | $139.6M | $103.5M | $67.0M | $81.6M | $43.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$39.2M | -$24.9M | -$16.5M | -$16.4M | -$19.3M | -$28.3M | -$38.7M | -$41.4M | -$45.4M | -$45.9M |
| Amortizaciones | $1.1M | $1.2M | $859000 | $494000 | $466000 | $451000 | $236000 | $398000 | $404000 | $904000 |
| Compensación en Acciones | $7.5M | $4.0M | $2.2M | $885000 | $1.8M | $3.2M | $4.3M | $4.5M | $4.8M | $5.7M |
| Cambio en Capital Circulante | $1.1M | -$3.1M | $98000 | $1.1M | -$654000 | -$1.8M | -$380000 | $6.6M | $3.2M | $2.2M |
| Flujo de Caja Operativo | -$31.0M | -$23.3M | -$13.2M | -$13.3M | -$16.3M | -$23.0M | -$33.8M | -$30.9M | -$37.7M | -$37.9M |
| Inversiones (CapEx) | -$823000 | -$100000 | -$5100 | -$68000 | -$211000 | -$205000 | -$892000 | -$582000 | -$80000 | -$44000 |
| Adquisiciones | $809.7M | $109.9M | $5100 | 0 | 0 | $205000 | -$114000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | -$24.2M | -$24.2M | -$24.2M | -$24.2M | 0 | -$24000 | -$414000 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$31.9M | -$23.4M | -$13.2M | -$13.3M | -$16.5M | -$23.2M | -$34.7M | -$31.5M | -$37.8M | -$38.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +32.5% | -25.1% | -35.3% | +49.6% | -1.9% | +7.5% | +26.4% | +40.0% | -13.2% | |
| Crecimiento Beneficio Neto (anual) | +36.5% | +33.9% | +0.3% | -17.6% | -46.5% | -36.8% | -7.1% | -9.6% | -0.9% | |
| Crecimiento BPA (anual) | +44.7% | +86.3% | +61.8% | +60.0% | +32.4% | -21.9% | -4.5% | -2.2% | +27.4% | |
| Cambio en Acciones (anual) | +14.5% | +383.8% | +156.4% | +249.4% | +87.0% | +11.7% | +2.5% | +6.7% | +40.3% | |
| Crecimiento FCF (anual) | +26.6% | +43.5% | -1.0% | -23.9% | -40.7% | -49.3% | +9.3% | -20.0% | -0.5% | |
| Margen Bruto | -354.1% | -258.6% | -57.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -10536.7% | -5068.5% | -4511.4% | -6817.8% | -5214.8% | -8037.6% | -10337.3% | -9305.7% | -7123.1% | -8256.3% |
| Margen EBITDA | -9647.9% | -4518.6% | -4153.4% | -6507.7% | -5147.3% | -7754.9% | -9965.8% | -8410.5% | -6592.5% | -7579.6% |
| Margen Neto | -10289.8% | -4932.1% | -4354.8% | -6709.7% | -5275.1% | -7880.5% | -10026.9% | -8492.0% | -6651.7% | -7732.0% |
| Margen FCF | -8363.0% | -4629.9% | -3493.4% | -5451.5% | -4515.3% | -6474.9% | -8992.7% | -6448.6% | -5530.5% | -6402.5% |
| Tasa Impositiva Efectiva | 0.8% | -2.9% | -3.8% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-75.76 | $-48.54 | $-5.67 | $-2.23 | $-0.79 | $-0.60 | $-0.80 | $-0.70 | $-0.79 | $-0.57 |
| Dividendo por Acción | $57.64 | $50.33 | $10.40 | $4.06 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $419096 | $481665 | $2.3M | $6.0M | $20.9M | $39.0M | $43.6M | $44.7M | $47.6M | $66.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -103.08% |
| Rentabilidad sobre capital invertido | -156.60% |
| Rentabilidad sobre activos | -107.29% |
| Margen bruto | 100.00% |
| Margen operativo | -8320.08% |
| Margen neto | -7884.06% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 3.30 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -1.62 | -0.43 | -0.45 | -0.46 | -16.66 | -8.23 | -1.57 | -1.59 | -4.57 | -4.07 |
| P/VC | 3.21 | 1.65 | 0.73 | 1.01 | 2.93 | 1.67 | 0.57 | 0.95 | 2.49 | 4.14 |
| P/V | 166.32 | 21.29 | 19.60 | 30.28 | 1026.07 | 653.40 | 158.13 | 135.50 | 302.78 | 316.73 |
| Margen Bruto | -354.1% | -258.6% | -57.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | -10536.7% | -5068.5% | -4511.4% | -6817.8% | -5214.8% | -8037.6% | -10337.3% | -9305.7% | -7123.1% | -8256.3% |
| Margen Neto | -10289.8% | -4932.1% | -4354.8% | -6709.7% | -5275.1% | -7880.5% | -10026.9% | -8492.0% | -6651.7% | -7732.0% |
Empresas relacionadas: APLT · CRBP · ELTX · FBRX · IPHA · MIST · MOLN
Explorar sector: Healthcare · Biotechnology
Más secciones de CRDF: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones